---
title: "Three Noteworthy Biotechs Just Reported Earnings — And Only One Recovered"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294722523.md"
description: "On Monday, leading biotech companies TG Therapeutics and Twist Bioscience saw contrasting performance in response to their earnings reports. Only one of these companies showed recovery after the announcement. The divergence in stock performance highlights the mixed results of the reports from these notable biotech firms."
datetime: "2026-08-03T17:14:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294722523.md)
  - [en](https://longbridge.com/en/news/294722523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294722523.md)
generator: "portal-rs"
---

# Three Noteworthy Biotechs Just Reported Earnings — And Only One Recovered

On Monday, leading biotech companies TG Therapeutics and Twist Bioscience saw contrasting performance in response to their earnings reports. Only one of these companies showed recovery after the announcement. The divergence in stock performance highlights the mixed results of the reports from these notable biotech firms.

### Related Stocks

- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)
- [TWST.US](https://longbridge.com/en/quote/TWST.US.md)

## Related News & Research

- [TG Therapeutics CEO Michael Weiss to join Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297906368.md)
- [AXQ Capital LP Takes Position in TG Therapeutics, Inc. $TGTX](https://longbridge.com/en/news/298125485.md)
- [Medicus Surges on New Data](https://longbridge.com/en/news/298337158.md)
- [Susquehanna Fundamental Investments LLC Takes Position in Twist Bioscience Corporation $TWST](https://longbridge.com/en/news/297631371.md)
- [Medicus Pharma pivots to precision oncology, prioritizing CD228V melanoma proof-of-concept study](https://longbridge.com/en/news/298310825.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**